Reaktion #2556

ord-3ff4585334ae4e29b75a677785e6dfac

Reaktionsgleichung

O=C(c1ccc(F)cc1)C1CCNCC1
4-(4-Fluorobenzoyl)piperidine
CCOC(CBr)OCC
bromoacetoaldehyde diethylacetal
CCN(CC)CC
triethylamine
CCOC(CN1CCC(C(=O)c2ccc(F)cc2)CC1)OCC
title compound
Ausbeute 25.0%
CCOC(CN1CCC(C(=O)c2ccc(F)cc2)CC1)OCC
1-(2,2-Diethoxyethyl)-4-(4-fluorobenzoyl)piperidine
Ausbeute 25.0%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturAfter 12 hours of heating
  2. 2
    Temperaturunder reflux
  3. 3
    Sonstigethe solvent was removed by evaporation
  4. 4
    Sonstigethe resulting residue was purified

Vorschrift

4-(4-Fluorobenzoyl)piperidine (207 mg, 1.0 mmol) was dissolved in methylene chloride (5 ml) to which were subsequently added bromoacetoaldehyde diethylacetal (305 mg, 1.5 mmol) and triethylamine (0.5 ml). After 12 hours of heating under reflux, the solvent was removed by evaporation, and the resulting residue was purified by subjecting it to a silica gel column chromatography (ether) to obtain 81 mg (25.0%) of the title compound in the form of orange oil.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05728835uspto-grants-1998_03